research Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
This article reviews the current FDA-approved treatments for severe pediatric alopecia areata, including the use of Janus kinase inhibitors, but reports no new clinical findings.
